Novo Nordisk
NVO
#77
Rank
A$322.29 B
Marketcap
A$72.53
Share price
0.88%
Change (1 day)
-56.49%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) Fails to deliver data

Key failure to deliver metrics for Novo Nordisk:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Novo Nordisk (NVO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Novo Nordisk (NVO) - since 2013

Volume in USD (price x number of shares), data since 2013

Novo Nordisk (NVO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$0.35 B43.62%
2024A$0.24 B179.42%
2023A$88.71 M-11.66%
2022A$0.10 B125.23%
2021A$44.58 M70.14%
2020A$26.2 M-57.24%
2019A$61.28 M-22.47%
2018A$79.04 M3.14%
2017A$76.63 M5.66%
2016A$72.53 M-28.24%
2015A$0.10 B-51.63%
2014A$0.20 B598.64%
2013A$29.9 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
A$24.63 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$0.21 BA$0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.09 MA$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$4.1 MA$62.72 M๐Ÿ‡ซ๐Ÿ‡ท France